Amanda Mumford, MD | |
2415 Helton Drive, Florence, AL 35630 | |
(256) 765-2230 | |
(256) 765-2084 |
Full Name | Amanda Mumford |
---|---|
Gender | Female |
Speciality | Psychiatry |
Experience | 41 Years |
Location | 2415 Helton Drive, Florence, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205882230 | NPI | - | NPPES |
51511393 | Other | AL | BCBS |
051511393 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 21327 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.
Parents who want their babies to sleep through the night would be wise to avoid co-sleeping arrangements or feeding their children evening snacks beyond early infancy.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
Researchers have developed an algorithm that matches or exceeds the ability of dermatologists to diagnose skin cancer, according to a new study. The study authors hope the technology can be integrated into Smartphones, to improve access to medical care.
Skin cancer is the most common form of cancer diagnosed in the United States, with one in five Americans expected to develop a form of skin cancer in their lifetime. Fortunately, there are simple steps people can take to reduce their skin cancer risk.
› Verified 5 days ago
Entity Name | Mission Medical Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114150190 PECOS PAC ID: 0749326106 Enrollment ID: O20100313000054 |
News Archive
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.
Parents who want their babies to sleep through the night would be wise to avoid co-sleeping arrangements or feeding their children evening snacks beyond early infancy.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
Researchers have developed an algorithm that matches or exceeds the ability of dermatologists to diagnose skin cancer, according to a new study. The study authors hope the technology can be integrated into Smartphones, to improve access to medical care.
Skin cancer is the most common form of cancer diagnosed in the United States, with one in five Americans expected to develop a form of skin cancer in their lifetime. Fortunately, there are simple steps people can take to reduce their skin cancer risk.
› Verified 5 days ago
Entity Name | Mission Health Community Multispecialty Providers Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.
Parents who want their babies to sleep through the night would be wise to avoid co-sleeping arrangements or feeding their children evening snacks beyond early infancy.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
Researchers have developed an algorithm that matches or exceeds the ability of dermatologists to diagnose skin cancer, according to a new study. The study authors hope the technology can be integrated into Smartphones, to improve access to medical care.
Skin cancer is the most common form of cancer diagnosed in the United States, with one in five Americans expected to develop a form of skin cancer in their lifetime. Fortunately, there are simple steps people can take to reduce their skin cancer risk.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Amanda Mumford, MD 2868 Acton Road, Birmingham, AL 35243 Ph: (205) 968-8360 | Amanda Mumford, MD 2415 Helton Drive, Florence, AL 35630 Ph: (256) 765-2230 |
News Archive
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.
Parents who want their babies to sleep through the night would be wise to avoid co-sleeping arrangements or feeding their children evening snacks beyond early infancy.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
Researchers have developed an algorithm that matches or exceeds the ability of dermatologists to diagnose skin cancer, according to a new study. The study authors hope the technology can be integrated into Smartphones, to improve access to medical care.
Skin cancer is the most common form of cancer diagnosed in the United States, with one in five Americans expected to develop a form of skin cancer in their lifetime. Fortunately, there are simple steps people can take to reduce their skin cancer risk.
› Verified 5 days ago
Roanna T Waynick, RN Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2415 Helton Drive, Suite A, Florence, AL 35630 Phone: 256-765-2230 Fax: 256-765-2084 | |
Georgie Stanford, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-765-2036 | |
David U Anakwenze, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2809 W Mall Dr, Florence, AL 35630 Phone: 256-767-4805 Fax: 256-767-4954 | |
Susana Sanchez Guzman, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-768-7462 | |
Dr. Timothy J Whalen, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2415 Helton Dr, Florence, AL 35630 Phone: 256-765-2230 Fax: 256-765-2084 | |
Dina Riyad Jannun, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 426 E Dr Hicks Blvd, Florence, AL 35630 Phone: 256-764-7721 Fax: 256-764-8589 |